Description
This is a 30-minute MOC Section 3 accredited eCME program for Canadian HCPs. This program provides evidence-based guidance on the management of primary biliary cholangitis (PBC), focusing on risk stratification, initiation of second-line therapy, and symptom management. Using a case-based approach, the program will explore strategies for timely treatment decisions, review evidence for second-line therapies (e.g., OCA, elafibranor), and highlight the importance of multidisciplinary collaboration to optimize patient-centered care.
Course Features:
– 2 video lectures,
– 2 interactive quizzes,
– 1 downloadable resource.
Content Covered:
Module 1: Evolving Landscape of PBC,
Module 2: PBC Management Second-Line Therapy,
Module 3: PBC Symptom Management.
This program has received financial support from Ipsen Biopharmaceuticals in the form of an unrestricted educational grant.